FR2172906A1 - Salts of 3-pyridyl methanol derivs - vasodilators - Google Patents

Salts of 3-pyridyl methanol derivs - vasodilators

Info

Publication number
FR2172906A1
FR2172906A1 FR7206564A FR7206564A FR2172906A1 FR 2172906 A1 FR2172906 A1 FR 2172906A1 FR 7206564 A FR7206564 A FR 7206564A FR 7206564 A FR7206564 A FR 7206564A FR 2172906 A1 FR2172906 A1 FR 2172906A1
Authority
FR
France
Prior art keywords
salts
derivs
vasodilators
pyridyl methanol
unsatd
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7206564A
Other languages
French (fr)
Other versions
FR2172906B1 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pierre Fabre SA
Original Assignee
Pierre Fabre SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pierre Fabre SA filed Critical Pierre Fabre SA
Priority to FR7206564A priority Critical patent/FR2172906A1/en
Publication of FR2172906A1 publication Critical patent/FR2172906A1/en
Application granted granted Critical
Publication of FR2172906B1 publication Critical patent/FR2172906B1/fr
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30Oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

New salts of formula (I): (where R = H, an unsatd. fatty acid residue, or pyroglutamoyl; R1 = halogen, an ion of a satd. or unsatd. fatty acid, or an ion of a pharmaceutically acceptable or acid esp. maleic, tartartic, citric, oxalic or pyroglutamic acids; R11 = H or lower alkyl), are prepd. by reaction of 3-pyridyl methanol with an acid chloride RCl followed by salt formation.
FR7206564A 1972-02-25 1972-02-25 Salts of 3-pyridyl methanol derivs - vasodilators Granted FR2172906A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR7206564A FR2172906A1 (en) 1972-02-25 1972-02-25 Salts of 3-pyridyl methanol derivs - vasodilators

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7206564A FR2172906A1 (en) 1972-02-25 1972-02-25 Salts of 3-pyridyl methanol derivs - vasodilators

Publications (2)

Publication Number Publication Date
FR2172906A1 true FR2172906A1 (en) 1973-10-05
FR2172906B1 FR2172906B1 (en) 1975-03-14

Family

ID=9094185

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7206564A Granted FR2172906A1 (en) 1972-02-25 1972-02-25 Salts of 3-pyridyl methanol derivs - vasodilators

Country Status (1)

Country Link
FR (1) FR2172906A1 (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2318632A1 (en) * 1975-07-25 1977-02-18 Fabre Sa Pierre SUBSTD. PYRIDINIUM FLUORIDE SALTS - esp. useful for treating and preventing dental caries
EP0055870A1 (en) * 1981-01-02 1982-07-14 Merck & Co. Inc. Pyridylmethyl esters of selected bio-affecting carboxylic acids, process for preparing and pharmaceutical composition comprising the same
EP0314275A2 (en) * 1987-08-20 1989-05-03 Kissei Pharmaceutical Co., Ltd. 2-Pyrrolidone-5-carboxylic acid compounds
WO2010013242A1 (en) * 2008-07-29 2010-02-04 Alcobra Ltd. Substituted pyridoxine-lactam carboxylate salts
WO2010150261A1 (en) * 2009-06-25 2010-12-29 Alcobra Ltd. A method for the treatment, alleviation of symptoms of, relieving, improving and preventing a cognitive disease, disorder or condition
US8476304B2 (en) 2007-07-03 2013-07-02 Alcobra Ltd. Method for decreasing symptoms of alcohol consumption

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2318632A1 (en) * 1975-07-25 1977-02-18 Fabre Sa Pierre SUBSTD. PYRIDINIUM FLUORIDE SALTS - esp. useful for treating and preventing dental caries
EP0055870A1 (en) * 1981-01-02 1982-07-14 Merck & Co. Inc. Pyridylmethyl esters of selected bio-affecting carboxylic acids, process for preparing and pharmaceutical composition comprising the same
EP0314275A2 (en) * 1987-08-20 1989-05-03 Kissei Pharmaceutical Co., Ltd. 2-Pyrrolidone-5-carboxylic acid compounds
EP0314275A3 (en) * 1987-08-20 1991-07-31 Kissei Pharmaceutical Co., Ltd. 2-pyrrolidone-5-carboxylic acid compounds
US8476304B2 (en) 2007-07-03 2013-07-02 Alcobra Ltd. Method for decreasing symptoms of alcohol consumption
US9808446B2 (en) 2007-07-03 2017-11-07 Alcobra Ltd. Method for decreasing symptoms of alcohol consumption
WO2010013242A1 (en) * 2008-07-29 2010-02-04 Alcobra Ltd. Substituted pyridoxine-lactam carboxylate salts
US8889715B2 (en) 2008-07-29 2014-11-18 Alcobra Ltd. Substituted pyridoxine-lactam carboxylate salts
US9428458B2 (en) 2008-07-29 2016-08-30 Alcobra Ltd. Substituted pyridoxine-lactam carboxylate-salts
WO2010150261A1 (en) * 2009-06-25 2010-12-29 Alcobra Ltd. A method for the treatment, alleviation of symptoms of, relieving, improving and preventing a cognitive disease, disorder or condition
US8710067B2 (en) 2009-06-25 2014-04-29 Alcobra Ltd. Method for the treatment, alleviation of symptoms of, relieving, improving and preventing a cognitive disease, disorder or condition
EA023758B1 (en) * 2009-06-25 2016-07-29 Алкобра Лтд. Use of metadoxine for treating attention deficit/hyperactivity disorder (adhd/add)

Also Published As

Publication number Publication date
FR2172906B1 (en) 1975-03-14

Similar Documents

Publication Publication Date Title
JPS5256190A (en) Process for producing polyvinyl pydolineeiodide aqueous solution
AR213169A1 (en) PROCEDURE FOR OBTAINING NEW COMPOUNDS DERIVED FROM ACID (1-OXO-2,2-DISUBSTITUTED-6,7-DIHALOINDANYLOXY ALKANAICOS
EG11278A (en) Process for preparing prostanoic acid derivatives
FR2172906A1 (en) Salts of 3-pyridyl methanol derivs - vasodilators
FI43187C (en) A process for the preparation of new, pharmacologically valuable salts of embonic acid
YU19274A (en) Process for obtainig new 1-benzene-2,2,3,4-tetrahydro-isoquinoline salts of theophylline-7-acetic acid
ES417078A1 (en) D-6-methyl-2,8-disubstituted ergolines
CA1004596A (en) Method of stabilizing dichlorocyanuric acid salts
HU172474B (en) Process for producing crystalline 7-bracket-d-2-hydroxy-2-phenyl-acetamido-bracket closed-3-bracket-1-methyl-1h--tetrazol-5-yl-thio-methyl-bracket closed-3-cepheme-4-carboxylic acid and sodium salt thereof, i.e. sodium-cephamandole
IL43341A0 (en) Process for the recovery of fluorine from an aqueous solution by ion exchange
ES399409A1 (en) Ether carboxylic acids
IE36597B1 (en) Process for preparing a 1,2-dihydrophthalazine
CA965959A (en) Process for recovery of dissolved mercury salts from aqueous solutions
ES412876A1 (en) Process for the production of succinylosuccinic diesters
DK131631B (en) Analogous process for the preparation of 4-oxo-benzo [4,5] cyclohepta / 1,2-b] thiophene-2-acetic acid compounds.
YU264480A (en) Process for obtaining the p-biphenylester of 11,15-bis-(tetrahydropyran-5-yloxy)-16-substituted tetranorprostadienic acid
NL7610683A (en) PROCESS FOR PREPARING AN ACID ADDITIONAL SALT OF A HETEROCYCLIC COMPOUND.
ES418746A1 (en) Gulonic acid salt
JPS5212919A (en) A method for preparing a stable prostaglandin f2alpha injection
ES405871A1 (en) Procedure for obtaining a ciproheptadine salt. (Machine-translation by Google Translate, not legally binding)
KR780000354B1 (en) Process for preparing 6-(2-aryl-2-(imidoylamino,alkanoylamino)acetamido)penicillanic acid
ES417230A1 (en) Pyridoxine salts
YU35105B (en) Process for preparing acetylamine derivatives of 2,4,6-triiodo-benzoic acid
DK134235B (en) Process for the preparation of salts of alpha-D-glucose-1-phosphoric acid.
CA1005050A (en) Process for the manufacture of new salts of acth-peptides

Legal Events

Date Code Title Description
TP Transmission of property
ST Notification of lapse